Natural Compounds as Inhibitors of Aβ Peptide and Tau Aggregation
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Neurodegenerative conditions like Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS) encompass disorders characterized by the degeneration of neurons in specific circumstances. The quest for novel agents to influence these diseases, particularly AD, has unearthed various natural compounds displaying multifaceted activities and diverse pharmacological mechanisms. Given the ongoing extensive study of pathways associated with the accumulation of neurofibrillary aggregates and amyloid plaques, this paper aims to comprehensively review around 130 studies exploring natural products. These studies focus on inhibiting the formation of amyloid plaques and tau protein tangles, with the objective of potentially alleviating or delaying AD.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
---|---|
Enthalten in: |
CNS & neurological disorders drug targets - (2023) vom: 28. Nov. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Monteiro, Kadja Luana Chagas [VerfasserIn] |
---|
Links: |
---|
Themen: |
Alzheimer’s disease |
---|
Anmerkungen: |
Date Revised 29.11.2023 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.2174/0118715273273539231114095300 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365093645 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM365093645 | ||
003 | DE-627 | ||
005 | 20231226100936.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/0118715273273539231114095300 |2 doi | |
028 | 5 | 2 | |a pubmed24n1216.xml |
035 | |a (DE-627)NLM365093645 | ||
035 | |a (NLM)38018200 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Monteiro, Kadja Luana Chagas |e verfasserin |4 aut | |
245 | 1 | 0 | |a Natural Compounds as Inhibitors of Aβ Peptide and Tau Aggregation |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 29.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a Neurodegenerative conditions like Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS) encompass disorders characterized by the degeneration of neurons in specific circumstances. The quest for novel agents to influence these diseases, particularly AD, has unearthed various natural compounds displaying multifaceted activities and diverse pharmacological mechanisms. Given the ongoing extensive study of pathways associated with the accumulation of neurofibrillary aggregates and amyloid plaques, this paper aims to comprehensively review around 130 studies exploring natural products. These studies focus on inhibiting the formation of amyloid plaques and tau protein tangles, with the objective of potentially alleviating or delaying AD | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Alzheimer’s disease | |
650 | 4 | |a Flavonoids | |
650 | 4 | |a Neurodegeneration | |
650 | 4 | |a Polyphenols | |
700 | 1 | |a de Aquino, Thiago Mendonça |e verfasserin |4 aut | |
700 | 1 | |a da Silva-Júnior, Edeildo Ferreira |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t CNS & neurological disorders drug targets |d 2006 |g (2023) vom: 28. Nov. |w (DE-627)NLM161975518 |x 1996-3181 |7 nnns |
773 | 1 | 8 | |g year:2023 |g day:28 |g month:11 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/0118715273273539231114095300 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2023 |b 28 |c 11 |